Medline Inc.
MDLN
$34.05
-$0.64-1.85%
NASDAQ
| 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | |
|---|---|---|---|---|---|
| Net Income | 693.00M | 966.00M | 1.16B | 1.27B | 1.27B |
| Total Depreciation and Amortization | 1.02B | 1.02B | 1.01B | 1.00B | 998.00M |
| Total Amortization of Deferred Charges | 53.00M | 55.00M | 59.00M | 60.00M | 60.00M |
| Total Other Non-Cash Items | 827.00M | 384.00M | 298.00M | 294.00M | 322.00M |
| Change in Net Operating Assets | -605.00M | -949.00M | -783.00M | -1.18B | -1.12B |
| Cash from Operations | 1.99B | 1.47B | 1.74B | 1.44B | 1.53B |
| Capital Expenditure | -446.00M | -478.00M | -480.00M | -433.00M | -439.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | 6.00M | 0.00 | -890.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -350.00M | -- | -- | 0.00 | -1.00M |
| Cash from Investing | -796.00M | -478.00M | -474.00M | -433.00M | -1.33B |
| Total Debt Issued | 12.30B | 7.57B | 7.75B | 14.04B | 8.65B |
| Total Debt Repaid | -16.41B | -11.66B | -11.84B | -14.10B | -9.20B |
| Issuance of Common Stock | 7.05B | 7.05B | 7.05B | -- | -- |
| Repurchase of Common Stock | -1.99B | -1.99B | -2.00B | -34.00M | -19.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -215.00M | -518.00M | -518.00M | -1.78B | -1.70B |
| Other Financing Activities | -166.00M | -49.00M | -36.00M | -8.00M | -11.00M |
| Cash from Financing | 564.00M | 395.00M | 399.00M | -1.89B | -2.29B |
| Foreign Exchange rate Adjustments | -15.00M | 7.00M | 23.00M | 22.00M | 23.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.75B | 1.40B | 1.69B | -861.00M | -2.07B |